|
|
Volumn 21, Issue 2, 2008, Pages 99-100
|
|
Graft vs. host disease: pathology, prophylaxis and therapy. GVHD overview
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOMODULATING AGENT;
ACUTE GRAFT VERSUS HOST DISEASE;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
AUTOIMMUNITY;
CHRONIC GRAFT VERSUS HOST DISEASE;
EDITORIAL;
EVIDENCE BASED MEDICINE;
GRAFT SURVIVAL;
HUMAN;
IMMUNE DEFICIENCY;
INFECTION RISK;
LYMPHOCYTE TRANSFUSION;
MEDICAL RESEARCH;
MORBIDITY;
MORTALITY;
PATHOPHYSIOLOGY;
PATIENT CARE;
PATIENT SAFETY;
PRIORITY JOURNAL;
PROPHYLAXIS;
QUALITY OF LIFE;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
GRAFT VS HOST DISEASE;
GRAFT VS LEUKEMIA EFFECT;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
|
|
EID: 44049085913
PISSN: 15216926
EISSN: None
Source Type: Journal
DOI: 10.1016/j.beha.2008.02.013 Document Type: Editorial |
|
Times cited : (8)
|
|
References (0)
|
